Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for BMRN

Stock Name	Biomarin Pharmaceutical Inc
Ticker	BMRN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US09061G1013
LEI	NSLL8ITTRR0J5HEMR848

Show aggregate BMRN holdings

News associated with BMRN

BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Lowered to $104.00 at The Goldman Sachs Group: BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its price target cut by The Goldman Sachs Group from $124.00 to $104.00 in a research report sent to investors on Monday,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. Other research analysts have also issued reports about the company. Oppenheimer raised BioMarin Pharmaceutical […] - 2025-05-06 05:56:44
NewEdge Advisors LLC Purchases 3,121 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): NewEdge Advisors LLC increased its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 1,200.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,381 shares of the biotechnology company’s stock after buying an additional 3,121 shares during the […] - 2025-05-02 08:18:50
BioMarin Pharmaceutical (NASDAQ:BMRN) Upgraded at StockNews.com: StockNews.com upgraded shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Friday. BMRN has been the topic of several other reports. Scotiabank lifted their price objective on shares of BioMarin Pharmaceutical from $78.00 to $80.00 and gave the stock a […] - 2025-04-28 05:56:51
After Hours Most Active for Apr 22, 2025 : TSLL, TSLA, NVDA, VZ, BMRN, CNH, KVUE, CM, CSCO, CLF, BAC, AAPL: The NASDAQ 100 After Hours Indicator is down -.37 to 18,276.04. The total After hours volume is currently 133,305,492 shares traded.The following are the most active stocks for the after hours session: Direxion Daily TSLA Bull 2X Shares (TSLL) is -0.1 at $7.29, with 10,940,890 s - 2025-04-22 20:24:52
Analysts Expect 26% Upside For The Holdings of IWS: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-17 12:43:07
Federated Hermes Inc. Sells 854 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Federated Hermes Inc. lessened its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 4.3% in the 4th quarter, HoldingsChannel.com reports. The fund owned 18,999 shares of the biotechnology company’s stock after selling 854 shares during the period. Federated Hermes Inc.’s holdings in BioMarin Pharmaceutical were worth $1,249,000 at the end of […] - 2025-04-15 08:34:53
CIBC Private Wealth Group LLC Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): CIBC Private Wealth Group LLC boosted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 64.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 596 shares of the biotechnology company’s stock after acquiring an additional 233 shares during […] - 2025-04-10 08:53:11
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $94.00 Consensus Target Price from Brokerages: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-four ratings firms that are presently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a hold rating and seventeen have issued a buy rating on the company. The average 12-month target price […] - 2025-04-02 05:35:01
Korea Investment CORP Purchases 131,600 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Korea Investment CORP grew its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 362.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 167,903 shares of the biotechnology company’s stock after purchasing an additional 131,600 shares during the quarter. Korea […] - 2025-03-31 08:45:10
Traders Purchase High Volume of Call Options on BioMarin Pharmaceutical (NASDAQ:BMRN): BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) was the target of some unusual options trading on Thursday. Traders bought 5,111 call options on the company. This represents an increase of 273% compared to the typical volume of 1,372 call options. Analyst Ratings Changes BMRN has been the subject of several recent analyst reports. Wedbush […] - 2025-03-28 07:07:10
5 Historically Cheap Growth Stocks to Buy With Confidence in the Wake of the Nasdaq Correction: Every so often, Wall Street sends a not-so-subtle reminder to investors that stocks can move in both directions. - 2025-03-27 09:06:00
Natixis Advisors LLC Purchases Shares of 19,738 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Natixis Advisors LLC acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 19,738 shares of the biotechnology company’s stock, valued at approximately $1,297,000. A number of other institutional investors and hedge […] - 2025-03-26 07:50:56
EverSource Wealth Advisors LLC Sells 6,469 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): EverSource Wealth Advisors LLC lowered its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 91.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 634 shares of the biotechnology company’s stock after selling 6,469 shares during the quarter. EverSource Wealth Advisors […] - 2025-03-21 08:25:03
BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Rating Upgraded by StockNews.com: BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Tuesday. BMRN has been the subject of several other research reports. Oppenheimer upgraded shares of BioMarin Pharmaceutical from a “market perform” rating to an “outperform” rating […] - 2025-03-18 06:12:54
How The Pieces Add Up: FBT Targets $219: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-17 11:50:34
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Acquired by M&T Bank Corp: M&T Bank Corp lifted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 9.5% during the fourth quarter, HoldingsChannel.com reports. The firm owned 7,085 shares of the biotechnology company’s stock after purchasing an additional 616 shares during the period. M&T Bank Corp’s holdings in BioMarin Pharmaceutical were worth $466,000 at the […] - 2025-03-14 08:08:58
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Consensus Rating of “Moderate Buy” by Brokerages: Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-four brokerages that are presently covering the stock, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation and seventeen have issued a buy recommendation on the company. The average 12-month price […] - 2025-03-05 07:12:53
Y Intercept Hong Kong Ltd Has $310,000 Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Y Intercept Hong Kong Ltd lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 83.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,711 shares of the biotechnology company’s stock after selling 23,519 shares during the quarter. […] - 2025-03-04 09:05:03
Sanctuary Advisors LLC Trims Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Sanctuary Advisors LLC lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 76.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,045 shares of the biotechnology company’s stock after selling 16,288 shares during the quarter. Sanctuary […] - 2025-03-04 08:22:48
New York State Common Retirement Fund Sells 4,600 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): New York State Common Retirement Fund reduced its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 4.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 93,645 shares of the biotechnology company’s stock after selling 4,600 shares during […] - 2025-02-28 09:04:56
Principal Securities Inc. Acquires 339 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Principal Securities Inc. boosted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 24.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,749 shares of the biotechnology company’s stock after buying an additional 339 shares […] - 2025-02-26 10:10:52
Asset Management One Co. Ltd. Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Asset Management One Co. Ltd. raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 76,785 shares of the biotechnology company’s stock after acquiring an additional 283 shares during the period. Asset Management One Co. Ltd.’s holdings in BioMarin Pharmaceutical were worth […] - 2025-02-19 10:44:54
Rhumbline Advisers Has $36.56 Million Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Rhumbline Advisers boosted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 2.0% in the fourth quarter, Holdings Channel reports. The firm owned 556,255 shares of the biotechnology company’s stock after purchasing an additional 11,025 shares during the quarter. Rhumbline Advisers’ holdings in BioMarin Pharmaceutical were worth $36,563,000 as of its most recent […] - 2025-02-19 09:03:32
Entropy Technologies LP Invests $500,000 in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Entropy Technologies LP acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,604 shares of the biotechnology company’s stock, valued at approximately $500,000. Other large […] - 2025-02-13 10:12:51
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock Holdings Trimmed by State of Alaska Department of Revenue: State of Alaska Department of Revenue cut its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 25.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 21,730 shares of the biotechnology company’s stock after selling 7,495 shares during the quarter. State […] - 2025-02-13 09:38:52
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Holdings Decreased by Janney Montgomery Scott LLC: Janney Montgomery Scott LLC trimmed its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 34.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,671 shares of the biotechnology company’s stock after selling 4,029 shares during the quarter. Janney Montgomery Scott LLC’s […] - 2025-02-10 18:10:54
Robeco Institutional Asset Management B.V. Trims Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Robeco Institutional Asset Management B.V. cut its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 58.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 86,574 shares of the biotechnology company’s stock after selling 124,092 shares during the […] - 2025-02-03 08:57:17

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) BMRN holdings

Date	Number of BMRN Shares Held	Base Market Value of BMRN Shares	Local Market Value of BMRN Shares	Change in BMRN Shares Held	Change in BMRN Base Value	Current Price per BMRN Share Held	Previous Price per BMRN Share Held
2025-05-08 (Thursday)	90,804	USD 5,431,895	USD 5,431,895	0	USD 45,402	USD 59.82	USD 59.32
2025-05-07 (Wednesday)	90,804	USD 5,386,493	USD 5,386,493	0	USD -29,058	USD 59.32	USD 59.64
2025-05-06 (Tuesday)	90,804	USD 5,415,551	USD 5,415,551	0	USD -219,745	USD 59.64	USD 62.06
2025-05-05 (Monday)	90,804	USD 5,635,296	USD 5,635,296	0	USD 2,724	USD 62.06	USD 62.03
2025-05-02 (Friday)	90,804	USD 5,632,572	USD 5,632,572	0	USD -61,747	USD 62.03	USD 62.71
2025-05-01 (Thursday)	90,804	USD 5,694,319	USD 5,694,319	0	USD -88,988	USD 62.71	USD 63.69
2025-04-30 (Wednesday)	90,804	USD 5,783,307	USD 5,783,307	0	USD 37,230	USD 63.69	USD 63.28
2025-04-29 (Tuesday)	90,804	USD 5,746,077	USD 5,746,077	0	USD 27,241	USD 63.28	USD 62.98
2025-04-28 (Monday)	90,804	USD 5,718,836	USD 5,718,836	0	USD -29,057	USD 62.98	USD 63.3
2025-04-25 (Friday)	90,804	USD 5,747,893	USD 5,747,893	0	USD 50,850	USD 63.3	USD 62.74
2025-04-24 (Thursday)	90,804	USD 5,697,043	USD 5,697,043	0	USD 72,643	USD 62.74	USD 61.94
2025-04-23 (Wednesday)	90,804	USD 5,624,400	USD 5,624,400	317	USD 59,449	USD 61.94	USD 61.5
2025-04-22 (Tuesday)	90,487	USD 5,564,951	USD 5,564,951	0	USD 257,888	USD 61.5	USD 58.65
2025-04-21 (Monday)	90,487	USD 5,307,063	USD 5,307,063	0	USD -47,053	USD 58.65	USD 59.17
2025-04-18 (Friday)	90,487	USD 5,354,116	USD 5,354,116	0	USD 0	USD 59.17	USD 59.17
2025-04-17 (Thursday)	90,487	USD 5,354,116	USD 5,354,116	0	USD 31,671	USD 59.17	USD 58.82
2025-04-16 (Wednesday)	90,487	USD 5,322,445	USD 5,322,445	0	USD -108,585	USD 58.82	USD 60.02
2025-04-15 (Tuesday)	90,487	USD 5,431,030	USD 5,431,030	0	USD 31,671	USD 60.02	USD 59.67
2025-04-14 (Monday)	90,487	USD 5,399,359	USD 5,399,359	0	USD 257,888	USD 59.67	USD 56.82
2025-04-11 (Friday)	90,487	USD 5,141,471	USD 5,141,471	0	USD 45,243	USD 56.82	USD 56.32
2025-04-10 (Thursday)	90,487	USD 5,096,228	USD 5,096,228	-2,536	USD -432,129	USD 56.32	USD 59.43
2025-04-09 (Wednesday)	93,023	USD 5,528,357	USD 5,528,357	0	USD 329,302	USD 59.43	USD 55.89
2025-04-08 (Tuesday)	93,023	USD 5,199,055	USD 5,199,055	-317	USD -322,939	USD 55.89	USD 59.16
2025-04-07 (Monday)	93,340	USD 5,521,994	USD 5,521,994	-317	USD -121,777	USD 59.16	USD 60.26
2025-04-04 (Friday)	93,657	USD 5,643,771	USD 5,643,771	-1,585	USD -863,162	USD 60.26	USD 68.32
2025-04-02 (Wednesday)	95,242	USD 6,506,933	USD 6,506,933	0	USD 36,192	USD 68.32	USD 67.94
2025-04-01 (Tuesday)	95,242	USD 6,470,741	USD 6,470,741	2,736	USD -68,508	USD 67.94	USD 70.69
2025-03-31 (Monday)	92,506	USD 6,539,249	USD 6,539,249	-936	USD -136,247	USD 70.69	USD 71.44
2025-03-28 (Friday)	93,442	USD 6,675,496	USD 6,675,496	0	USD -129,885	USD 71.44	USD 72.83
2025-03-27 (Thursday)	93,442	USD 6,805,381	USD 6,805,381	0	USD 126,147	USD 72.83	USD 71.48
2025-03-26 (Wednesday)	93,442	USD 6,679,234	USD 6,679,234	0	USD -4,672	USD 71.48	USD 71.53
2025-03-25 (Tuesday)	93,442	USD 6,683,906	USD 6,683,906	0	USD -42,984	USD 71.53	USD 71.99
2025-03-24 (Monday)	93,442	USD 6,726,890	USD 6,726,890	0	USD 70,082	USD 71.99	USD 71.24
2025-03-21 (Friday)	93,442	USD 6,656,808	USD 6,656,808	3,808	USD 239,014	USD 71.24	USD 71.6
2025-03-20 (Thursday)	89,634	USD 6,417,794	USD 6,417,794	0	USD 25,097	USD 71.6	USD 71.32
2025-03-19 (Wednesday)	89,634	USD 6,392,697	USD 6,392,697	0	USD -17,927	USD 71.32	USD 71.52
2025-03-18 (Tuesday)	89,634	USD 6,410,624	USD 6,410,624	0	USD -2,689	USD 71.52	USD 71.55
2025-03-17 (Monday)	89,634	USD 6,413,313	USD 6,413,313	0	USD 189,128	USD 71.55	USD 69.44
2025-03-14 (Friday)	89,634	USD 6,224,185	USD 6,224,185	-4,784	USD -441,726	USD 69.44	USD 70.6
2025-03-13 (Thursday)	94,418	USD 6,665,911	USD 6,665,911	0	USD 5,665	USD 70.6	USD 70.54
2025-03-12 (Wednesday)	94,418	USD 6,660,246	USD 6,660,246	0	USD 4,721	USD 70.54	USD 70.49
2025-03-11 (Tuesday)	94,418	USD 6,655,525	USD 6,655,525	0	USD -145,404	USD 70.49	USD 72.03
2025-03-10 (Monday)	94,418	USD 6,800,929	USD 6,800,929	0	USD -18,883	USD 72.03	USD 72.23
2025-03-07 (Friday)	94,418	USD 6,819,812	USD 6,819,812	-598	USD 53,723	USD 72.23	USD 71.21
2025-03-06 (Thursday)	95,016	USD 6,766,089	USD 6,766,089	0	USD 1,900	USD 71.21	USD 71.19
2025-03-05 (Wednesday)	95,016	USD 6,764,189	USD 6,764,189	0	USD 64,611	USD 71.19	USD 70.51
2025-03-04 (Tuesday)	95,016	USD 6,699,578	USD 6,699,578	-299	USD -69,693	USD 70.51	USD 71.02
2025-03-03 (Monday)	95,315	USD 6,769,271	USD 6,769,271	0	USD -13,344	USD 71.02	USD 71.16
2025-02-28 (Friday)	95,315	USD 6,782,615	USD 6,782,615	0	USD 194,442	USD 71.16	USD 69.12
2025-02-27 (Thursday)	95,315	USD 6,588,173	USD 6,588,173	0	USD 29,548	USD 69.12	USD 68.81
2025-02-26 (Wednesday)	95,315	USD 6,558,625	USD 6,558,625	0	USD -224,944	USD 68.81	USD 71.17
2025-02-25 (Tuesday)	95,315	USD 6,783,569	USD 6,783,569	598	USD 247,622	USD 71.17	USD 69.005
2025-02-24 (Monday)	94,717	USD 6,535,947	USD 6,535,947	0	USD 71,512	USD 69.005	USD 68.25
2025-02-21 (Friday)	94,717	USD 6,464,435	USD 6,464,435	0	USD -45,464	USD 68.25	USD 68.73
2025-02-20 (Thursday)	94,717	USD 6,509,899	USD 6,509,899	0	USD 295,517	USD 68.73	USD 65.61
2025-02-19 (Wednesday)	94,717	USD 6,214,382	USD 6,214,382	-299	USD 51,644	USD 65.61	USD 64.86
2025-02-18 (Tuesday)	95,016	USD 6,162,738	USD 6,162,738	0	USD 950	USD 64.86	USD 64.85
2025-02-17 (Monday)	95,016	USD 6,161,788	USD 6,161,788	0	USD 0	USD 64.85	USD 64.85
2025-02-14 (Friday)	95,016	USD 6,161,788	USD 6,161,788	0	USD 40,857	USD 64.85	USD 64.42
2025-02-13 (Thursday)	95,016	USD 6,120,931	USD 6,120,931	897	USD -77,746	USD 64.42	USD 65.86
2025-02-12 (Wednesday)	94,119	USD 6,198,677	USD 6,198,677	299	USD 236,416	USD 65.86	USD 63.55
2025-02-11 (Tuesday)	93,820	USD 5,962,261	USD 5,962,261	1,196	USD 80,637	USD 63.55	USD 63.5
2025-02-10 (Monday)	92,624	USD 5,881,624	USD 5,881,624	0	USD -39,828	USD 63.5	USD 63.93
2025-02-07 (Friday)	92,624	USD 5,921,452	USD 5,921,452	0	USD -37,976	USD 63.93	USD 64.34
2025-02-06 (Thursday)	92,624	USD 5,959,428	USD 5,959,428	0	USD 14,357	USD 64.34	USD 64.185
2025-02-05 (Wednesday)	92,624	USD 5,945,071	USD 5,945,071	0	USD 121,800	USD 64.185	USD 62.87
2025-02-04 (Tuesday)	92,624	USD 5,823,271	USD 5,823,271	0	USD 39,828	USD 62.87	USD 62.44
2025-02-03 (Monday)	92,624	USD 5,783,443	USD 5,783,443	0	USD -85,214	USD 62.44	USD 63.36
2025-01-31 (Friday)	92,624	USD 5,868,657	USD 5,868,657	0	USD -48,164	USD 63.36	USD 63.88
2025-01-30 (Thursday)	92,624	USD 5,916,821	USD 5,916,821	0	USD 38,902	USD 63.88	USD 63.46
2025-01-29 (Wednesday)	92,624	USD 5,877,919	USD 5,877,919	0	USD 19,451	USD 63.46	USD 63.25
2025-01-28 (Tuesday)	92,624	USD 5,858,468	USD 5,858,468	0	USD 134,305	USD 63.25	USD 61.8
2025-01-27 (Monday)	92,624	USD 5,724,163	USD 5,724,163	0	USD 6,483	USD 61.8	USD 61.73
2025-01-24 (Friday)	92,624	USD 5,717,680	USD 5,717,680	0	USD -42,607	USD 61.73	USD 62.19
2025-01-23 (Thursday)	92,624	USD 5,760,287	USD 5,760,287	0	USD 15,747	USD 62.19	USD 62.02
2025-01-22 (Wednesday)	92,624	USD 5,744,540	USD 5,744,540
2025-01-21 (Tuesday)	92,624	USD 5,791,779	USD 5,791,779
2025-01-20 (Monday)	92,624	USD 5,699,155	USD 5,699,155
2025-01-17 (Friday)	92,624	USD 5,699,155	USD 5,699,155
2025-01-16 (Thursday)	91,428	USD 5,599,965	USD 5,599,965
2025-01-15 (Wednesday)	90,232	USD 5,556,487	USD 5,556,487
2025-01-14 (Tuesday)	90,232	USD 5,757,704	USD 5,757,704
2025-01-13 (Monday)	90,232	USD 6,044,642	USD 6,044,642
2025-01-10 (Friday)	90,232	USD 6,079,832	USD 6,079,832
2025-01-09 (Thursday)	90,830	USD 6,210,955	USD 6,210,955
2025-01-09 (Thursday)	90,830	USD 6,210,955	USD 6,210,955
2025-01-09 (Thursday)	90,830	USD 6,210,955	USD 6,210,955
2025-01-08 (Wednesday)	90,830	USD 6,210,955	USD 6,210,955
2025-01-08 (Wednesday)	90,830	USD 6,210,955	USD 6,210,955
2025-01-08 (Wednesday)	90,830	USD 6,210,955	USD 6,210,955
2025-01-02 (Thursday)	92,026	USD 6,118,809	USD 6,118,809	366	USD 119,662	USD 66.49	USD 65.45
2024-12-30 (Monday)	91,660	USD 5,999,147	USD 5,999,147	-10,504	USD -787,608	USD 65.45	USD 66.43
2024-12-10 (Tuesday)	102,164	USD 6,786,755	USD 6,786,755	0	USD -38,822	USD 66.43	USD 66.81
2024-12-09 (Monday)	102,164	USD 6,825,577	USD 6,825,577	0	USD 7,152	USD 66.81	USD 66.74
2024-12-06 (Friday)	102,164	USD 6,818,425	USD 6,818,425	0	USD 59,255	USD 66.74	USD 66.16
2024-12-05 (Thursday)	102,164	USD 6,759,170	USD 6,759,170	0	USD -35,758	USD 66.16	USD 66.51
2024-12-04 (Wednesday)	102,164	USD 6,794,928	USD 6,794,928	0	USD 339,185	USD 66.51	USD 63.19
2024-12-03 (Tuesday)	102,164	USD 6,455,743	USD 6,455,743	0	USD -189,004	USD 63.19	USD 65.04
2024-12-02 (Monday)	102,164	USD 6,644,747	USD 6,644,747	0	USD -101,142	USD 65.04	USD 66.03
2024-11-29 (Friday)	102,164	USD 6,745,889	USD 6,745,889	0	USD 62,320	USD 66.03	USD 65.42
2024-11-28 (Thursday)	102,164	USD 6,683,569	USD 6,683,569	0	USD 0	USD 65.42	USD 65.42
2024-11-27 (Wednesday)	102,164	USD 6,683,569	USD 6,683,569	0	USD 55,169	USD 65.42	USD 64.88
2024-11-26 (Tuesday)	102,164	USD 6,628,400	USD 6,628,400	0	USD -21,455	USD 64.88	USD 65.09
2024-11-25 (Monday)	102,164	USD 6,649,855	USD 6,649,855	0	USD 84,796	USD 65.09	USD 64.26
2024-11-22 (Friday)	102,164	USD 6,565,059	USD 6,565,059	0	USD 82,753	USD 64.26	USD 63.45
2024-11-21 (Thursday)	102,164	USD 6,482,306	USD 6,482,306	0	USD 90,926	USD 63.45	USD 62.56
2024-11-20 (Wednesday)	102,164	USD 6,391,380	USD 6,391,380	0	USD 60,277	USD 62.56	USD 61.97
2024-11-19 (Tuesday)	102,164	USD 6,331,103	USD 6,331,103	0	USD 4,086	USD 61.97	USD 61.93
2024-11-18 (Monday)	102,164	USD 6,327,017	USD 6,327,017	-4,890	USD -752,464	USD 61.93	USD 66.13
2024-11-12 (Tuesday)	107,054	USD 7,079,481	USD 7,079,481	0	USD -100,631	USD 66.13	USD 67.07
2024-11-08 (Friday)	107,054	USD 7,180,112	USD 7,180,112	-326	USD -7,905	USD 67.07	USD 66.94
2024-11-07 (Thursday)	107,380	USD 7,188,017	USD 7,188,017	0	USD 84,830	USD 66.94	USD 66.15
2024-11-06 (Wednesday)	107,380	USD 7,103,187	USD 7,103,187	0	USD 11,812	USD 66.15	USD 66.04
2024-11-05 (Tuesday)	107,380	USD 7,091,375	USD 7,091,375	0	USD 3,221	USD 66.04	USD 66.01
2024-11-04 (Monday)	107,380	USD 7,088,154	USD 7,088,154	0	USD -63,354	USD 66.01	USD 66.6
2024-11-01 (Friday)	107,380	USD 7,151,508	USD 7,151,508	0	USD 76,240	USD 66.6	USD 65.89
2024-10-31 (Thursday)	107,380	USD 7,075,268	USD 7,075,268	0	USD -84,830	USD 65.89	USD 66.68
2024-10-30 (Wednesday)	107,380	USD 7,160,098	USD 7,160,098	0	USD -346,838	USD 66.68	USD 69.91
2024-10-29 (Tuesday)	107,380	USD 7,506,936	USD 7,506,936	0	USD -23,623	USD 69.91	USD 70.13
2024-10-28 (Monday)	107,380	USD 7,530,559	USD 7,530,559	0	USD 42,952	USD 70.13	USD 69.73
2024-10-25 (Friday)	107,380	USD 7,487,607	USD 7,487,607	0	USD -70,871	USD 69.73	USD 70.39
2024-10-24 (Thursday)	107,380	USD 7,558,478	USD 7,558,478	0	USD 44,026	USD 70.39	USD 69.98
2024-10-23 (Wednesday)	107,380	USD 7,514,452	USD 7,514,452	0	USD -59,059	USD 69.98	USD 70.53
2024-10-22 (Tuesday)	107,380	USD 7,573,511	USD 7,573,511	0	USD 26,845	USD 70.53	USD 70.28
2024-10-21 (Monday)	107,380	USD 7,546,666	USD 7,546,666	-326	USD -4,602	USD 70.28	USD 70.11
2024-10-18 (Friday)	107,706	USD 7,551,268	USD 7,551,268

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BMRN by Blackrock for IE00BYXG2H39

Show aggregate share trades of BMRN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-04-23 BUY 317 61.940* 66.13
2025-04-10 SELL -2,536 56.320* 66.86 Profit of 169,568 on sale
2025-04-08 SELL -317 55.890* 67.08 Profit of 21,263 on sale
2025-04-07 SELL -317 59.160* 67.17 Profit of 21,292 on sale
2025-04-04 SELL -1,585 60.260* 67.25 Profit of 106,590 on sale
2025-04-01 BUY 2,736 67.940* 67.23
2025-03-31 SELL -936 70.690* 67.19 Profit of 62,886 on sale
2025-03-21 BUY 3,808 71.240* 66.83
2025-03-14 SELL -4,784 69.440* 66.53 Profit of 318,257 on sale
2025-03-07 SELL -598 72.230* 66.17 Profit of 39,571 on sale
2025-03-04 SELL -299 70.510* 65.94 Profit of 19,717 on sale
2025-02-25 BUY 598 71.170* 65.57
2025-02-19 SELL -299 65.610* 65.40 Profit of 19,555 on sale
2025-02-13 BUY 897 64.420* 65.45
2025-02-12 BUY 299 65.860* 65.44
2025-02-11 BUY 1,196 63.550* 65.48
2025-01-02 BUY 366 66.490* 66.35
2024-12-30 SELL -10,504 65.450* 66.37 Profit of 697,195 on sale
2024-11-18 SELL -4,890 61.930* 68.03 Profit of 332,661 on sale
2024-11-08 SELL -326 67.070* 68.23 Profit of 22,244 on sale
2024-10-21 SELL -326 70.280* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-04-23	BUY	317	61.940*	66.13
2025-04-10	SELL	-2,536	56.320*	66.86 Profit of 169,568 on sale
2025-04-08	SELL	-317	55.890*	67.08 Profit of 21,263 on sale
2025-04-07	SELL	-317	59.160*	67.17 Profit of 21,292 on sale
2025-04-04	SELL	-1,585	60.260*	67.25 Profit of 106,590 on sale
2025-04-01	BUY	2,736	67.940*	67.23
2025-03-31	SELL	-936	70.690*	67.19 Profit of 62,886 on sale
2025-03-21	BUY	3,808	71.240*	66.83
2025-03-14	SELL	-4,784	69.440*	66.53 Profit of 318,257 on sale
2025-03-07	SELL	-598	72.230*	66.17 Profit of 39,571 on sale
2025-03-04	SELL	-299	70.510*	65.94 Profit of 19,717 on sale
2025-02-25	BUY	598	71.170*	65.57
2025-02-19	SELL	-299	65.610*	65.40 Profit of 19,555 on sale
2025-02-13	BUY	897	64.420*	65.45
2025-02-12	BUY	299	65.860*	65.44
2025-02-11	BUY	1,196	63.550*	65.48
2025-01-02	BUY	366	66.490*	66.35
2024-12-30	SELL	-10,504	65.450*	66.37 Profit of 697,195 on sale
2024-11-18	SELL	-4,890	61.930*	68.03 Profit of 332,661 on sale
2024-11-08	SELL	-326	67.070*	68.23 Profit of 22,244 on sale
2024-10-21	SELL	-326	70.280*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BMRN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-05-09	111,048	0	406,915	27.3%
2025-05-08	229,822	59	583,186	39.4%
2025-05-07	144,552	900	485,365	29.8%
2025-05-06	205,031	1,340	499,836	41.0%
2025-05-05	180,438	168	430,655	41.9%
2025-05-02	430,077	3,788	904,432	47.6%
2025-05-01	219,694	1,403	491,056	44.7%
2025-04-30	235,058	26	390,531	60.2%
2025-04-29	174,326	31	437,740	39.8%
2025-04-28	127,460	254	523,544	24.3%
2025-04-25	102,763	184	238,974	43.0%
2025-04-24	121,268	1,606	361,577	33.5%
2025-04-23	275,391	221	400,292	68.8%
2025-04-22	269,870	1,503	576,869	46.8%
2025-04-21	186,783	470	426,049	43.8%
2025-04-17	160,393	87	316,388	50.7%
2025-04-16	206,325	126	367,335	56.2%
2025-04-15	230,108	940	627,328	36.7%
2025-04-14	227,981	842	632,667	36.0%
2025-04-11	177,321	327	857,724	20.7%
2025-04-10	504,599	3,132	979,222	51.5%
2025-04-09	376,563	2,136	1,505,394	25.0%
2025-04-08	287,293	492	744,643	38.6%
2025-04-07	397,089	3,588	1,598,590	24.8%
2025-04-04	387,547	2,415	1,422,795	27.2%
2025-04-03	193,095	0	648,102	29.8%
2025-04-02	121,215	0	542,092	22.4%
2025-04-01	115,325	0	427,655	27.0%
2025-03-31	251,245	13,914	455,639	55.1%
2025-03-28	190,559	0	493,391	38.6%
2025-03-27	260,518	0	547,813	47.6%
2025-03-26	244,045	2,886	546,385	44.7%
2025-03-25	111,993	1,199	292,460	38.3%
2025-03-24	104,078	42	304,119	34.2%
2025-03-21	391,710	30	553,999	70.7%
2025-03-20	183,806	11,851	323,579	56.8%
2025-03-19	169,649	992	366,339	46.3%
2025-03-18	146,912	131	376,154	39.1%
2025-03-17	110,703	2,527	311,881	35.5%
2025-03-14	262,788	2,376	450,080	58.4%
2025-03-13	119,066	1	258,146	46.1%
2025-03-12	139,647	12,744	389,910	35.8%
2025-03-11	162,058	891	348,828	46.5%
2025-03-10	212,225	1,129	531,131	40.0%
2025-03-07	348,932	6,231	608,064	57.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE